Aclaris Therapeutics (NASDAQ:ACRS) Coverage Initiated at Cantor Fitzgerald
Stock analysts at Cantor Fitzgerald initiated coverage on shares of Aclaris Therapeutics (NASDAQ:ACRS – Get Free Report) in a research report issued on Tuesday, Marketbeat Ratings reports. The firm set an “overweight” rating on the biotechnology company’s stock. A number of other equities research analysts also recently issued reports on the company. Leerink Partnrs upgraded […]
Stock analysts at Cantor Fitzgerald initiated coverage on shares of Aclaris Therapeutics (NASDAQ:ACRS – Get Free Report) in a research report issued on Tuesday, Marketbeat Ratings reports. The firm set an “overweight” rating on the biotechnology company’s stock. A number of other equities research analysts also recently issued reports on the company. Leerink Partnrs upgraded […]
-logo-1200x675.gif&w=240&h=240&zc=2){kind=logo}
